期刊文献+

载甲哌利福霉素-PMMA复合物的制备

原文传递
导出
摘要 目的:制备载甲哌利福霉素-聚甲基丙烯酸甲酯(polymethyl methacrylate PMMA)复合物,在外观上观察其状态、孔隙率及剖面形态。方法:将甲哌利福霉素与PMMA按一定比例混合,用模具制成载甲哌利福霉素-PMMA复合物,观察其样本大体像、微观结构及孔隙率。结果:制备载甲哌利福霉素-PMMA复合物呈圆柱状体,坚固稳定,能维持其状态不出现崩塌。电镜观察显示该载甲哌利福霉素-PMMA复合物呈多孔结构,粉粒黏结良好,微孔分布均匀,孔径分布50~100um,孔隙率检测为(34.76±2.53)%。结论:载甲哌利福霉素-PMMA复合物复合物坚固稳定,呈多孔结构,微孔分布均匀。
出处 《贵阳中医学院学报》 2016年第2期67-68,共2页 Journal of Guiyang University of Chinese Medicine
基金 贵州省高层次人才科研条件特助经费项目 项目编号:TZJF-2009-15号
  • 相关文献

参考文献7

  • 1MastrogiacomoM, Muraglia A, Kmolev V, et al. Tissue engineering of bone : search for a better scaffold [ J ]. Orthod Craniofac Res,2005.4:27 - 284.
  • 2Jones JR. Ahir S. Hench LL. Large -scale production of 3D bioactive glassma - croporous scaffolds for tissue engineering [J]. J SolGelSciTech, 2004,29 ( 3 ) : 179 - 188.
  • 3Wu P, Grainger D W. Drug/device combinations for lo- cal drug therapies and infection prophylaxis [ J ]. Bio- materials ,2006,11:2450 - 2467.
  • 4Shi M, Kretlow JD, Spieer PP, el al Antibiotic -relea- sing porous polymethacrylate/gelatin/antibiotie con- structs for craniofacial tissue engineering [ J ]. J Control Release ,2011,1 : 196 - 205.
  • 5Higuchui T. Rate of release of medicaments from oint- ment bases containing drugs in suspension. J Pharm Sci. 1961 ;50:874 - 875.
  • 6叶向阳,甄平,李晓飞,张增山,赵东华.磷酸钙骨水泥药物缓释体系的研究应用[J].中国组织工程研究与临床康复,2009,13(47):9317-9320. 被引量:7
  • 7杨彦君,熊屹,易洪城,吕英,彭长英,唐良华.载利福平-骨水泥复合物的生物相容性研究[J].贵阳中医学院学报,2014,36(1):27-30. 被引量:6

二级参考文献33

  • 1唐佩福,黄晋香,王继芳,卢世璧,王岩,卢世琳,贺大为.多孔碳酸化羟基磷灰石骨水泥的生物相容性研究[J].北京生物医学工程,2005,24(6):401-404. 被引量:4
  • 2李娟莹,张超武.磷酸钙骨水泥作为药物缓释载体的研究[J].陶瓷,2006(6):12-15. 被引量:5
  • 3Constantz BR, Ison IC, Fulmer MT, et al. Skeletal repair by in situ formation of the mineral phase of bone. Science. 1995;267(5205): 1796-1799.
  • 4Takezawa T. A strategy for the development of tissue engineering scaffolds that regulate cell behavior. Biomaterials. 2003; 24(13):2267- 2275.
  • 5Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials. 2000;21 (24):2529-2543.
  • 6Arkfeld DG, Rubenstein E. Quest for the Holy Grail to cure arthritis and osteoporosis: emphasis on bone drug delivery systems. Adv Drug Deliv Rev. 2005;57(7):939-944.
  • 7Brown WE, Chow LC. A new calcium phosphate setting cement.J Dent Res. 1983;(63) :762.
  • 8Brown WE, Chow LC.A new calcium phosphate, water-setting cement.In: Brown PW. Cements Research Progress. Westerville:American Ceramic Society. 1987:351-379.
  • 9Liu CS, Shen W, Gu YF, et al. Mechanism of hardening process for nonceramic hydroxyapatite. J Biomed Mat Res. 1997 ;35(1 ):75-80.
  • 10Otsuka M, Matsuda Y, Suwa Y, et al. A novel skeletal drug delivery system using self-setting calcium phosphate cement. 2. Physicochemical properties and drug release rate of the cement-containing indomethacin. J Pharm Sci. 1994;83(5):611-615.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部